Cytokeratin 17 (BSB-33) Mouse
Cytokeratin 17 (BSB-33) Mouse
| Application | IHC |
| Clone | BSB-33 |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | Synthetic peptide corresponding to human Cytokeratin 17 protein |
| Isotype | IgG2a kappa |
| Localisation | Cytoplasmic |
| Pathologie | Ovarian Cancer, Cervical Cancer, Lung Cancer, Breast Cancer, Gall Bladder, Pancreatic Cancer, Carcinoma of Unknown Primary Site |
| Predicted reactivity | |
| Purification | |
| Réactivité | Human, Rat, Goat, Pig |
| Spécificité | |
| Taille | |
| Tissus controles | Skin, Testis, Breast, Cervix, Cervical Carcinoma, Bladder TCC |
Prêt à l'emploi
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 15 ml | BSB2728 |
|
IVD/CE | RTU |
|
|
| 7 ml | BSB2727 |
|
IVD/CE | RTU |
|
|
| 3 ml | BSB2726 |
|
IVD/CE | RTU |
|
Concentré
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 1 ml | BSB2731 |
|
IVD/CE | 1/25 - 1/100 |
|
|
| 0,5 ml | BSB2730 |
|
IVD/CE | 1/25 - 1/100 |
|
|
| 0,1 ml | BSB2729 |
|
IVD/CE | 1/25 - 1/100 |
|
Control Slides
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 5 slides | BSB2732 |
|
IVD/CE |
|